JP2017532959A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532959A5 JP2017532959A5 JP2017519013A JP2017519013A JP2017532959A5 JP 2017532959 A5 JP2017532959 A5 JP 2017532959A5 JP 2017519013 A JP2017519013 A JP 2017519013A JP 2017519013 A JP2017519013 A JP 2017519013A JP 2017532959 A5 JP2017532959 A5 JP 2017532959A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- gene
- threshold
- mdm2i
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 49
- 108090000623 proteins and genes Proteins 0.000 claims 24
- 206010028980 Neoplasm Diseases 0.000 claims 14
- 230000014509 gene expression Effects 0.000 claims 11
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 claims 8
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 claims 8
- 201000011510 cancer Diseases 0.000 claims 7
- 230000035945 sensitivity Effects 0.000 claims 7
- 230000002018 overexpression Effects 0.000 claims 6
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 claims 4
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 claims 4
- 238000009826 distribution Methods 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 102100032500 40S ribosomal protein S27-like Human genes 0.000 claims 2
- 102100034150 Apoptosis-enhancing nuclease Human genes 0.000 claims 2
- 229940126062 Compound A Drugs 0.000 claims 2
- 108010016788 Cyclin-Dependent Kinase Inhibitor p21 Proteins 0.000 claims 2
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 claims 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 2
- 101000731896 Homo sapiens 40S ribosomal protein S27-like Proteins 0.000 claims 2
- 101000780559 Homo sapiens Apoptosis-enhancing nuclease Proteins 0.000 claims 2
- 101000928259 Homo sapiens NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 claims 2
- 102100036777 NADPH:adrenodoxin oxidoreductase, mitochondrial Human genes 0.000 claims 2
- 101150080074 TP53 gene Proteins 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 101150024228 mdm2 gene Proteins 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 108700025694 p53 Genes Proteins 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- -1 spiro oxindole derivative Chemical class 0.000 claims 2
- NUKCQDDVORQLDB-OLILMLBXSA-N (3s)-4-[(1r)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3h-1,4-benzodiazepine-2,5-dione Chemical compound C1([C@@H]2N(C(C3=CC(I)=CC=C3N(CCCN3CCN(C)CC3)C2=O)=O)[C@H](C)C=2C(=CC(Cl)=CC=2)N)=CC=C(Cl)C=C1 NUKCQDDVORQLDB-OLILMLBXSA-N 0.000 claims 1
- 102100036413 2',5'-phosphodiesterase 12 Human genes 0.000 claims 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical class C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 claims 1
- BDUHCSBCVGXTJM-WUFINQPMSA-N 4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone Chemical compound CC(C)OC1=CC(OC)=CC=C1C1=N[C@@H](C=2C=CC(Cl)=CC=2)[C@@H](C=2C=CC(Cl)=CC=2)N1C(=O)N1CC(=O)NCC1 BDUHCSBCVGXTJM-WUFINQPMSA-N 0.000 claims 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 claims 1
- 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 claims 1
- CLRSLRWKONPSRQ-IIPSPAQQSA-N C1([C@@H]2N(C(=O)CC=3C=C(C(=CC=32)OC(C)C)OC)C=2C=CC(=CC=2)N(C)C[C@@H]2CC[C@H](CC2)N2CC(=O)N(C)CC2)=CC=C(Cl)C=C1 Chemical compound C1([C@@H]2N(C(=O)CC=3C=C(C(=CC=32)OC(C)C)OC)C=2C=CC(=CC=2)N(C)C[C@@H]2CC[C@H](CC2)N2CC(=O)N(C)CC2)=CC=C(Cl)C=C1 CLRSLRWKONPSRQ-IIPSPAQQSA-N 0.000 claims 1
- 102100021122 DNA damage-binding protein 2 Human genes 0.000 claims 1
- 102100035481 DNA polymerase eta Human genes 0.000 claims 1
- 102000016251 GREB1 Human genes 0.000 claims 1
- 108050004787 GREB1 Proteins 0.000 claims 1
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 claims 1
- 101001072024 Homo sapiens 2',5'-phosphodiesterase 12 Proteins 0.000 claims 1
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 claims 1
- 101001041466 Homo sapiens DNA damage-binding protein 2 Proteins 0.000 claims 1
- 101001094607 Homo sapiens DNA polymerase eta Proteins 0.000 claims 1
- 101000865085 Homo sapiens DNA polymerase theta Proteins 0.000 claims 1
- 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 claims 1
- 101001032502 Homo sapiens Iron-sulfur cluster assembly enzyme ISCU, mitochondrial Proteins 0.000 claims 1
- 101001033754 Homo sapiens Mediator of RNA polymerase II transcription subunit 31 Proteins 0.000 claims 1
- 101000574631 Homo sapiens Meteorin Proteins 0.000 claims 1
- 101000645266 Homo sapiens Mitochondrial import inner membrane translocase subunit Tim22 Proteins 0.000 claims 1
- 101000583714 Homo sapiens Pleckstrin homology-like domain family A member 3 Proteins 0.000 claims 1
- 101001105683 Homo sapiens Pre-mRNA-processing-splicing factor 8 Proteins 0.000 claims 1
- 101000842302 Homo sapiens Protein-cysteine N-palmitoyltransferase HHAT Proteins 0.000 claims 1
- 101000717450 Homo sapiens RCC1 and BTB domain-containing protein 1 Proteins 0.000 claims 1
- 101001061669 Homo sapiens Required for excision 1-B domain-containing protein Proteins 0.000 claims 1
- 101000929936 Homo sapiens Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 claims 1
- 101000701936 Homo sapiens Signal peptidase complex subunit 1 Proteins 0.000 claims 1
- 101000618110 Homo sapiens Sperm-associated antigen 7 Proteins 0.000 claims 1
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims 1
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims 1
- 102100038096 Iron-sulfur cluster assembly enzyme ISCU, mitochondrial Human genes 0.000 claims 1
- 102100039122 Mediator of RNA polymerase II transcription subunit 31 Human genes 0.000 claims 1
- 102100025695 Meteorin Human genes 0.000 claims 1
- 102100026258 Mitochondrial import inner membrane translocase subunit Tim22 Human genes 0.000 claims 1
- 102100030925 Pleckstrin homology-like domain family A member 3 Human genes 0.000 claims 1
- 102100021231 Pre-mRNA-processing-splicing factor 8 Human genes 0.000 claims 1
- 102100030616 Protein-cysteine N-palmitoyltransferase HHAT Human genes 0.000 claims 1
- 102100020837 RCC1 and BTB domain-containing protein 1 Human genes 0.000 claims 1
- 102100028426 Required for excision 1-B domain-containing protein Human genes 0.000 claims 1
- 102100035766 Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 claims 1
- 102100030313 Signal peptidase complex subunit 1 Human genes 0.000 claims 1
- 102100021912 Sperm-associated antigen 7 Human genes 0.000 claims 1
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims 1
- QBGKPEROWUKSBK-QPPIDDCLSA-N [(4s,5r)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C(N([C@]1(C)C=2C=CC(Cl)=CC=2)C(=O)N2CCN(CCCS(C)(=O)=O)CC2)=N[C@@]1(C)C1=CC=C(Cl)C=C1 QBGKPEROWUKSBK-QPPIDDCLSA-N 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 150000002475 indoles Chemical class 0.000 claims 1
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical class C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- VLJNHYLEOZPXFW-UHFFFAOYSA-N pyrrolidine-2-carboxamide Chemical class NC(=O)C1CCCN1 VLJNHYLEOZPXFW-UHFFFAOYSA-N 0.000 claims 1
- 150000004040 pyrrolidinones Chemical class 0.000 claims 1
- 238000012795 verification Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462061992P | 2014-10-09 | 2014-10-09 | |
| US62/061,992 | 2014-10-09 | ||
| PCT/JP2015/079389 WO2016056673A1 (en) | 2014-10-09 | 2015-10-09 | Algorithms for gene signature-based predictor of sensitivity to mdm2 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017532959A JP2017532959A (ja) | 2017-11-09 |
| JP2017532959A5 true JP2017532959A5 (cg-RX-API-DMAC7.html) | 2018-11-22 |
Family
ID=54396934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017519013A Withdrawn JP2017532959A (ja) | 2014-10-09 | 2015-10-09 | Ｍｄｍ２阻害剤に対する感受性の遺伝子シグネチャーに基づく予測因子に関するアルゴリズム |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20170283885A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3204514A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017532959A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016056673A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160061439A (ko) | 2007-03-28 | 2016-05-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
| RU2639523C2 (ru) | 2011-10-18 | 2017-12-21 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы и их применение |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| US9604919B2 (en) | 2012-11-01 | 2017-03-28 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| WO2016049355A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
| SG11201702223UA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
| EP3294318A4 (en) | 2015-03-20 | 2019-04-03 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF |
| GB201517217D0 (en) | 2015-09-29 | 2015-11-11 | Astex Therapeutics Ltd And Cancer Res Technology Ltd | Pharmaceutical compounds |
| GB201517216D0 (en) | 2015-09-29 | 2015-11-11 | Cancer Res Technology Ltd And Astex Therapeutics Ltd | Pharmaceutical compounds |
| TW201818934A (zh) * | 2016-10-17 | 2018-06-01 | 日商第一三共股份有限公司 | Ｍｄｍ２抑制劑與ｄｎａ甲基轉移酶抑制劑之倂用治療法 |
| CN107974502B (zh) * | 2016-10-19 | 2021-07-02 | 北京大学人民医院 | 一种用于同时检测nbpf10、tsfm、prb2及diaph1基因突变的试剂盒 |
| GB201704965D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201704966D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| RU2747746C2 (ru) * | 2018-10-24 | 2021-05-13 | Общество с ограниченной ответственностью «Онкобокс» | Тест-классификатор клинического ответа на лечение сорафенибом индивидуальных пациентов с раком почки |
| GB201919219D0 (en) | 2019-12-23 | 2020-02-05 | Otsuka Pharma Co Ltd | Cancer biomarkers |
| WO2021228814A1 (en) * | 2020-05-15 | 2021-11-18 | ETH Zürich | Mdm2 inhibitor response prediction method |
| GB202103080D0 (en) | 2021-03-04 | 2021-04-21 | Otsuka Pharma Co Ltd | Cancer biomarkers |
| WO2023009173A1 (en) * | 2021-07-30 | 2023-02-02 | Oregon Health & Science University | Methods for selecting melanoma patients for therapy and methods of reducing or preventing melanoma metastasis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20140409T1 (hr) * | 2009-01-16 | 2014-06-06 | Daiichi Sankyo Company, Limited | Derivat imidazola sa strukturom prolinskog prstena |
| MY172862A (en) * | 2011-03-10 | 2019-12-13 | Daiichi Sankyo Co Ltd | Dispiropyrrolidine derivatives |
| US20120328692A1 (en) * | 2011-06-24 | 2012-12-27 | University Of Maryland, Baltimore | Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy |
| US20150159222A1 (en) * | 2012-07-31 | 2015-06-11 | Novartis Ag | Markers associated with human double minute 2 inhibitors |
| WO2014065760A1 (en) * | 2012-10-25 | 2014-05-01 | Agency For Science, Technology And Research | Methods for determining resistance against molecules targeting proteins |
| BR112015031542A2 (pt) * | 2013-07-03 | 2017-07-25 | Hoffmann La Roche | métodos de previsão de reação de pacientes com câncer, método de tratamento de câncer, kit de previsão da reação ao tratamento e processos, métodos e usos inovadores |
-
2015
- 2015-10-09 JP JP2017519013A patent/JP2017532959A/ja not_active Withdrawn
- 2015-10-09 EP EP15790296.6A patent/EP3204514A1/en not_active Withdrawn
- 2015-10-09 US US15/510,892 patent/US20170283885A1/en not_active Abandoned
- 2015-10-09 WO PCT/JP2015/079389 patent/WO2016056673A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532959A5 (cg-RX-API-DMAC7.html) | ||
| Westphal et al. | Circulating biomarkers for gliomas | |
| Fry et al. | Activation of inflammation/NF-κB signaling in infants born to arsenic-exposed mothers | |
| JP2017508442A5 (cg-RX-API-DMAC7.html) | ||
| JP2021501318A5 (cg-RX-API-DMAC7.html) | ||
| Slaby et al. | Significant overexpression of Hsp110 gene during colorectal cancer progression | |
| Diaz Jr et al. | Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA | |
| Anaka et al. | Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors | |
| Yuan et al. | Identification of a Nine Immune‐Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma | |
| Liu et al. | A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia | |
| Zhang et al. | Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma | |
| JP2022522354A (ja) | 肝がん再発予測用ｄｎａメチル化マーカー及びその用途 | |
| Yu et al. | Genome-wide analysis of genetic variations assisted by Ingenuity Pathway Analysis to comprehensively investigate potential genetic targets associated with the progression of hepatocellular carcinoma | |
| Qi et al. | A four-mRNA model to improve the prediction of breast cancer prognosis | |
| Cruz‐Granados et al. | Multiomic‐based immune response profiling in migraine, vestibular migraine and Meniere's disease | |
| Li et al. | Significance of pyroptosis-related gene in the diagnosis and classification of rheumatoid arthritis | |
| Niu et al. | Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma | |
| Lu et al. | Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis | |
| Wei et al. | Identification and validation of IFI44 as a novel biomarker for primary Sjögren’s syndrome | |
| Yang et al. | Single‐cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers | |
| CN113736879A (zh) | 用于小细胞肺癌患者预后的系统及其应用 | |
| WO2021249355A1 (zh) | 用于选择化疗响应患者组的生物标志物和方法及其用途 | |
| JP2014501496A5 (cg-RX-API-DMAC7.html) | ||
| Yang et al. | Candida albicans triggers the expression of inflammatory genes in human umbilical vein endothelial cells | |
| Wen et al. | Prognostic value of PRR11 and immune cell infiltration in Ewing sarcoma |